Dev Institute Of Nuclear Medicine Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.27 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 12.85 Cr
- Revenue Growth -2.08%
- Profit Growth 1.47%
- Ebitda -8.17%
- Net Worth 24.37%
- Total Assets 6.54%
About Dev Institute Of Nuclear Medicine
Dev Institute Of Nuclear Medicine Private Limited (DIONMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 April 2004 and has a history of 20 years and ten months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.27 Cr.
The company currently has active open charges totaling ₹12.85 Cr.
Sangeeta Srivastva, Bipin Srivastava, Vihag Raman, and Two other members serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110BR2004PTC010679
- Company No.
010679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2004
- Date of AGM
31 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Dev Institute Of Nuclear Medicine?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vihag Raman  | Director | 12-Apr-2015 | Current |
| Sangeeta Srivastva | Director | 08-Apr-2004 | Current |
| Bipin Srivastava | Director | 12-Apr-2015 | Current |
| Ravi Kumar | Director | 15-Jan-2018 | Current |
| Girish Srivastava | Director | 20-Apr-2021 | Current |
Financial Performance of Dev Institute Of Nuclear Medicine.
Dev Institute Of Nuclear Medicine Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.08% decrease. The company also saw a slight improvement in profitability, with a 1.47% increase in profit. The company's net worth Soared by an impressive increase of 24.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dev Institute Of Nuclear Medicine?
In 2021, Dev Institute Of Nuclear Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nuclear Imaging And Therapy LlpSangeeta Srivastva and Bipin Srivastava are mutual person
- Asrb Medical Services Private Limited
Sangeeta Srivastva and Bipin Srivastava are mutual person
- Raman Imaging And Diagnostic Private Limited
Vihag Raman is a mutual person
- Suryansh Imaging Private Limited
Ravi Kumar is a mutual person
- Oceanik Buildtech And Constructions Private Limited
Girish Srivastava is a mutual person
Charges (Loans)
₹12.85 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 4.94 Cr
- Hdfc Bank Limited : 3.49 Cr
- Siemens Financial Services Private Limited : 3.47 Cr
- Bank Of Baroda : 0.65 Cr
- India Infoline Finance Limited : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹4.43 M | Open |
| 31 Dec 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 26 Jun 2019 | Others | ₹4.50 Cr | Open |
| 12 Feb 2016 | Hdfc Bank Limited | ₹3.24 Cr | Open |
| 30 Mar 2015 | India Infoline Finance Limited | ₹2.94 M | Open |
How Many Employees Work at Dev Institute Of Nuclear Medicine?
Dev Institute Of Nuclear Medicine has a workforce of 11 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dev Institute Of Nuclear Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Institute Of Nuclear Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
